Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
SHR-3276 in Advanced Solid Tumors
NCT06643754Phase 2Recruiting
- Sponsor
- Suzhou Suncadia Biopharmaceutical
- Start
- Dec 2024
- Primary completion
- Dec 2027
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of SHR-3276 in solid tumor (advanced stage), sponsored by Suzhou Suncadia Biopharmaceutical. Started Dec 2024; status: recruiting.
02
Drugs
SHR-3276
03
Conditions
solid tumor (advanced stage)
Beyond the preview
Go deeper on NCT06643754.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06643754.